Neuropathic Pain Market : TOC

  1. Home
  2. Life Sciences & Transformational Health
  3. Neuropathic Pain Market
  4. Table of Content
  • Published On : Jul-2018 |
  • Pages : 211 Pages |
  • Format :

Table of Content:

1. Executive Summary
   1.1. Market Overview
   1.2. Market Analysis
   1.3. PMR Analysis and Recommendations
   1.4. Wheel of Fortune
 
2. Market Introduction
   2.1. Market Definition
   2.2. Market Taxonomy
   2.3. Inclusion and Exclusion
 
3. Global Economic Outlook
   3.1. Gross Domestic Product by Region & Country, 2006 – 2021
   3.2. Medical Devices Sector Outlook
   3.3. Healthcare Indicators
 
4. Neuropathic Pain Management Market Opportunity Analysis
   4.1. Macro-Economic Factors
   4.2. Opportunity Analysis
 
5. Market View Point
   5.1. Macro-Economic Factors
   5.2. Opportunity Analysis
   5.3. Drivers
        5.3.1. Supply Side Drivers
        5.3.2. Demand Side Drivers
   5.4. Restraints
   5.5. Trends
 
6. Macroeconomic Assumptions
 
7. North America Neuropathic Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
   7.1. Introduction
   7.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
        7.2.1. U.S.
        7.2.2. Canada
   7.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
   7.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Class 2013–2017
        7.4.1. Tricyclic Anti-Depressants
        7.4.2. Anticonvulsants
        7.4.3. SNRI's
        7.4.4. Capsaicin Cream
        7.4.5. Local Anesthesia
        7.4.6. Opioids
        7.4.7. Steroids
        7.4.8. Others
   7.5. Market Size (US$ Mn) Forecast By Drug Class 2018–2026
   7.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2017
        7.6.1. Diabetic Neuropathy
        7.6.2. Trigeminal Neuralgia
        7.6.3. Post-Herpetic Neuralgia
        7.6.4. Chemotherapy-Induced Peripheral Neuropathy
        7.6.5. Others
   7.7. Market Size (US$ Mn) Forecast By Indication, 2018–2026
   7.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
        7.8.1. Retail Pharmacies
        7.8.2. Hospital Pharmacies
        7.8.3. Online Pharmacies
   7.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
   7.10. Market Attractiveness Analysis
        7.10.1. By Country
        7.10.2. By Drug Class
        7.10.3. By Indication
        7.10.4. By Distribution Channel
   7.11. Key Market Participants – Intensity Mapping
   7.12. Drivers and Restraints – Impact Analysis
 
8. Latin America Neuropathic Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
   8.1. Introduction
   8.2. Regional Market Trends
   8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
        8.3.1. Argentina
        8.3.2. Brazil
        8.3.3. Mexico
        8.3.4. Rest of Latin America
   8.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
   8.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Class 2013–2017
        8.5.1. Tricyclic Anti-Depressants
        8.5.2. Anticonvulsants
        8.5.3. SNRI's
        8.5.4. Capsaicin Cream
        8.5.5. Local Anesthesia
        8.5.6. Opioids
        8.5.7. Steroids
        8.5.8. Others
   8.6. Market Size (US$ Mn) Forecast By Drug Class 2018–2026
   8.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2017
        8.7.1. Diabetic Neuropathy
        8.7.2. Trigeminal Neuralgia
        8.7.3. Post-Herpetic Neuralgia
        8.7.4. Chemotherapy-Induced Peripheral Neuropathy
        8.7.5. Others
   8.8. Market Size (US$ Mn) Forecast By Indication, 2018–2026
   8.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
        8.9.1. Retail Pharmacies
        8.9.2. Hospital Pharmacies
        8.9.3. Online Pharmacies
   8.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
   8.11. Market Attractiveness Analysis
        8.11.1. By Country
        8.11.2. By Drug Class
        8.11.3. By Indication
        8.11.4. By Distribution Channel
   8.12. Key Market Participants – Intensity Mapping
   8.13. Drivers and Restraints – Impact Analysis
 
9. Europe Neuropathic Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
Market forecast and analysis in Germany, U.K., France, Italy, Spain, Russia and rest of Europe
   9.1. Introduction
   9.2. Regional Market Trends
   9.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
        9.3.1. Germany
        9.3.2. U.K.
        9.3.3. France
        9.3.4. Italy
        9.3.5. Spain
        9.3.6. Russia
        9.3.7. Rest of Europe
   9.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
   9.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Class 2013–2017
        9.5.1. Tricyclic Anti-Depressants
        9.5.2. Anticonvulsants
        9.5.3. SNRI's
        9.5.4. Capsaicin Cream
        9.5.5. Local Anesthesia
        9.5.6. Opioids
        9.5.7. Steroids
        9.5.8. Others
   9.6. Market Size (US$ Mn) Forecast By Drug Class 2018–2026
   9.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2017
        9.7.1. Diabetic Neuropathy
        9.7.2. Trigeminal Neuralgia
        9.7.3. Post-Herpetic Neuralgia
        9.7.4. Chemotherapy-Induced Peripheral Neuropathy
        9.7.5. Others
   9.8. Market Size (US$ Mn) Forecast By Indication, 2018–2026
   9.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
        9.9.1. Retail Pharmacies
        9.9.2. Hospital Pharmacies
        9.9.3. Online Pharmacies
   9.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
   9.11. Market Attractiveness Analysis
        9.11.1. By Country
        9.11.2. By Drug Class
        9.11.3. By Indication
        9.11.4. By Distribution Channel
   9.12. Key Market Participants – Intensity Mapping
   9.13. Drivers and Restraints – Impact Analysis
 
10. Asia-Pacific Excluding China Neuropathic Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
   10.1. Introduction
   10.2. Regional Market Trends
   10.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
        10.3.1. Japan
        10.3.2. India
        10.3.3. Australia and New Zealand
        10.3.4. Rest of Asia Pacific
   10.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
   10.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Class 2013–2017
        10.5.1. Tricyclic Anti-Depressants
        10.5.2. Anticonvulsants
        10.5.3. SNRI's
        10.5.4. Capsaicin Cream
        10.5.5. Local Anesthesia
        10.5.6. Opioids
        10.5.7. Steroids
        10.5.8. Others
   10.6. Market Size (US$ Mn) Forecast By Drug Class 2018–2026
   10.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2017
        10.7.1. Diabetic Neuropathy
        10.7.2. Trigeminal Neuralgia
        10.7.3. Post-Herpetic Neuralgia
        10.7.4. Chemotherapy-Induced Peripheral Neuropathy
        10.7.5. Others
   10.8. Market Size (US$ Mn) Forecast By Indication, 2018–2026
   10.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
        10.9.1. Retail Pharmacies
        10.9.2. Hospital Pharmacies
        10.9.3. Online Pharmacies
   10.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
   10.11. Market Attractiveness Analysis
        10.11.1. By Country
        10.11.2. By Drug Class
        10.11.3. By Indication
        10.11.4. By Distribution Channel
   10.12. Key Market Participants – Intensity Mapping
   10.13. Drivers and Restraints – Impact Analysis
 
11. Middle East & Africa Neuropathic Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
Market forecast and analysis in GCC Countries, South Africa, and rest of MEA
   11.1. Introduction
   11.2. Key Regulations
   11.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
        11.3.1. GCC Countries
        11.3.2. South Africa
        11.3.3. Rest of MEA
   11.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
   11.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Class 2013–2017
        11.5.1. Tricyclic Anti-Depressants
        11.5.2. Anticonvulsants
        11.5.3. SNRI's
        11.5.4. Capsaicin Cream
        11.5.5. Local Anesthesia
        11.5.6. Opioids
        11.5.7. Steroids
        11.5.8. Others
   11.6. Market Size (US$ Mn) Forecast By Drug Class 2018–2026
   11.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2017
        11.7.1. Diabetic Neuropathy
        11.7.2. Trigeminal Neuralgia
        11.7.3. Post-Herpetic Neuralgia
        11.7.4. Chemotherapy-Induced Peripheral Neuropathy
        11.7.5. Others
   11.8. Market Size (US$ Mn) Forecast By Indication, 2018–2026
   11.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
        11.9.1. Retail Pharmacies
        11.9.2. Hospital Pharmacies
        11.9.3. Online Pharmacies
   11.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
   11.11. Market Attractiveness Analysis
        11.11.1. By Country
        11.11.2. By Drug Class
        11.11.3. By Indication
        11.11.4. By Distribution Channel
   11.12. Key Market Participants – Intensity Mapping
   11.13. Drivers and Restraints – Impact Analysis
 
12. Forecast Factors: Relevance and Impact
 
13. Forecast Assumptions
 
14. Competition Analysis
   14.1. Market Structure by Tier of Companies
   14.2. Competition Dashboard
   14.3. Competition Benchmarking
   14.4. Company Deep Dive
        14.4.1. Pfizer Inc.
               14.4.1.1. Overview
               14.4.1.2. Product and Technology Portfolio
               14.4.1.3. Production Footprint
               14.4.1.4. Sales Footprint
               14.4.1.5. Channel Footprint
               14.4.1.6. Strategy
                        14.4.1.6.1. Marketing Strategy
                        14.4.1.6.2. Product Strategy
                        14.4.1.6.3. Channel Strategy
        14.4.2. Johnson & Johnson Services, Inc
               14.4.2.1. Overview
               14.4.2.2. Product and Technology Portfolio
               14.4.2.3. Production Footprint
               14.4.2.4. Sales Footprint
               14.4.2.5. Channel Footprint
               14.4.2.6. Strategy
                        14.4.2.6.1. Marketing Strategy
                        14.4.2.6.2. Product Strategy
                        14.4.2.6.3. Channel Strategy
        14.4.3. Sanofi S.A.
               14.4.3.1. Overview
               14.4.3.2. Product and Technology Portfolio
               14.4.3.3. Production Footprint
               14.4.3.4. Sales Footprint
               14.4.3.5. Channel Footprint
               14.4.3.6. Strategy
                        14.4.3.6.1. Marketing Strategy
                        14.4.3.6.2. Product Strategy
                        14.4.3.6.3. Channel Strategy
        14.4.4. GlaxoSmithKline plc.
               14.4.4.1. Overview
               14.4.4.2. Product and Technology Portfolio
               14.4.4.3. Production Footprint
               14.4.4.4. Sales Footprint
               14.4.4.5. Channel Footprint
               14.4.4.6. Strategy
                        14.4.4.6.1. Marketing Strategy
                        14.4.4.6.2. Product Strategy
                        14.4.4.6.3. Channel Strategy
        14.4.5. Eli Lilly and Company
               14.4.5.1. Overview
               14.4.5.2. Product and Technology Portfolio
               14.4.5.3. Production Footprint
               14.4.5.4. Sales Footprint
               14.4.5.5. Channel Footprint
               14.4.5.6. Strategy
                        14.4.5.6.1. Marketing Strategy
                        14.4.5.6.2. Product Strategy
                        14.4.5.6.3. Channel Strategy
        14.4.6. Bristol-Myers Squibb
               14.4.6.1. Overview
               14.4.6.2. Product and Technology Portfolio
               14.4.6.3. Production Footprint
               14.4.6.4. Sales Footprint
               14.4.6.5. Channel Footprint
               14.4.6.6. Strategy
                        14.4.6.6.1. Marketing Strategy
                        14.4.6.6.2. Product Strategy
                        14.4.6.6.3. Channel Strategy
        14.4.7. Biogen Idec, Inc.
               14.4.7.1. Overview
               14.4.7.2. Product and Technology Portfolio
               14.4.7.3. Production Footprint
               14.4.7.4. Sales Footprint
               14.4.7.5. Channel Footprint
               14.4.7.6. Strategy
                        14.4.7.6.1. Marketing Strategy
                        14.4.7.6.2. Product Strategy
                        14.4.7.6.3. Channel Strategy
        14.4.8. Baxter Healthcare Corporation
               14.4.8.1. Overview
               14.4.8.2. Product and Technology Portfolio
               14.4.8.3. Production Footprint
               14.4.8.4. Sales Footprint
               14.4.8.5. Channel Footprint
               14.4.8.6. Strategy
                        14.4.8.6.1. Marketing Strategy
                        14.4.8.6.2. Product Strategy
                        14.4.8.6.3. Channel Strategy
        14.4.9. Depomed, Inc.
               14.4.9.1. Overview
               14.4.9.2. Product and Technology Portfolio
               14.4.9.3. Production Footprint
               14.4.9.4. Sales Footprint
               14.4.9.5. Channel Footprint
               14.4.9.6. Strategy
                        14.4.9.6.1. Marketing Strategy
                        14.4.9.6.2. Product Strategy
                        14.4.9.6.3. Channel Strategy
 
15. Global Neuropathic Pain Management Market Analysis 2013–2017 and Forecast 2018–2026, By Region
   15.1. Introduction/Key Findings
   15.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017
   15.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
        15.3.1. North America
        15.3.2. Latin America
        15.3.3. Europe
        15.3.4. Asia-Pacific
        15.3.5. Middle East & Africa
   15.4. Market Attractiveness Analysis By Region
 
16. Global Neuropathic Pain Management Market Analysis 2013–2017 and Forecast 2018–2026, By Drug Class
   16.1. Introduction/Key Findings
   16.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Class 2013–2017
        16.2.1. Tricyclic Anti-Depressants
        16.2.2. Anticonvulsants
        16.2.3. SNRI's
        16.2.4. Capsaicin Cream
        16.2.5. Local Anesthesia
        16.2.6. Opioids
        16.2.7. Steroids
        16.2.8. Others
   16.3. Market Size (US$ Mn) Forecast By Drug Class 2018–2026
   16.4. Market Attractiveness Analysis By Drug Class
 
17. Global Neuropathic Pain Management Market Analysis 2013–2017 and Forecast 2018–2026, By Indication
   17.1. Introduction/Key Findings
   17.2. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013–2017
        17.2.1. Diabetic Neuropathy
        17.2.2. Trigeminal Neuralgia
        17.2.3. Post-Herpetic Neuralgia
        17.2.4. Chemotherapy-Induced Peripheral Neuropathy
        17.2.5. Others
   17.3. Market Size (US$ Mn) Forecast By Indication, 2018–2026
   17.4. Market Attractiveness Analysis By Indication
 
18. Global Neuropathic Pain Management Market Analysis 2013–2017 and Forecast 2018–2026, By Distribution Channel
   18.1. Introduction/Key Findings
   18.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
        18.2.1. Retail Pharmacies
        18.2.2. Hospital Pharmacies
        18.2.3. Online Pharmacies
   18.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
   18.4. Market Attractiveness Analysis By Distribution Channel
 
19. Global Neuropathic Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
   19.1. Market Value Share Analysis By All Segment
   19.2. Y-o-Y Growth Analysis By All Segment
   19.3. Absolute $ Opportunity
 
20. Research Methodology
 

List of Tables

 
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021 (1/2)
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021 (2/2)
Table 03: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 04: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 05: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
Table 06: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 07: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 08: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 09: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
Table 10: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 11: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 12: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 13: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
Table 14: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 15: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 16: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 17: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
Table 18: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 19: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 20: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 21: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
Table 22: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 23: Global Neuropathic Pain Management Size (US$ Mn) 2012–2016 and Forecast 2018-2026 By Region, 
Table 24: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 25: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
Table 26: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel

List of Figures

Figure 01: Global Neuropathic Pain Management Market Value Share By Drug Class (2018 E)
Figure 02: Global Neuropathic Pain Management Market Value Share By Indication (2018 E)
Figure 03: Global Neuropathic Pain Management Market Value Share By Distribution Channel (2018 E)
Figure 05: Global Neuropathic Pain Management Market Value Share By Region (2018 E)
Figure 06: North America Neuropathic Pain Management Market Value Share By Drug Class (2018 E)
Figure 07: North America Neuropathic Pain Management Market Value Share By Indication (2018 E)
Figure 08: North America Neuropathic Pain Management Market Value Share By Distribution Channel (2018 E)
Figure 09: North America Neuropathic Pain Management Market Value Share By Country (2018 E)
Figure 10: North America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 11: North America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 12: U.S. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 13: U.S. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 14: Canada Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 15: Canada Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 16: North America Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2018-2026
Figure 17: North America Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2018-2026
Figure 18: North America Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2018-2026
Figure 19: North America Neuropathic Pain Management Market Attractiveness Analysis By Country, 2018-2026
Figure 20: Latin America Neuropathic Pain Management Market Value Share By Drug Class (2018 E)
Figure 21: Latin America Neuropathic Pain Management Market Value Share By Indication (2018 E)
Figure 22: Latin America Neuropathic Pain Management Market Value Share By Distribution Channel (2018 E)
Figure 23: Latin America Neuropathic Pain Management Market Value Share By Country (2018 E)
Figure 24: Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 25: Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 26: Brazil Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 27: Brazil Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 28: Mexico Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 29: Mexico Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 30: Argentina Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 31: Argentina Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 32: Rest of Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 33: Rest of Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 34: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2018-2026
Figure 35: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2018-2026
Figure 36: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2018-2026
Figure 37: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Country, 2018-2026
Figure 38: Europe Neuropathic Pain Management Market Value Share By Drug Class (2018 E)
Figure 39: Europe Neuropathic Pain Management Market Value Share By Indication (2018 E)
Figure 40: Europe Neuropathic Pain Management Market Value Share By Distribution Channel (2018 E)
Figure 41: Europe Neuropathic Pain Management Market Value Share By Country (2018 E)
Figure 42: Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 43: Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 44: U.K. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 45: U.K. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 46: Germany Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-201754
Figure 47: Germany Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 48: France Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 49: France Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 50: Italy Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 51: Italy Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 52: Spain Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 53: Spain Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 54: Russia Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 55: Russia Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 56: Rest of Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 57: Rest of Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 58: Europe Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2018-2026
Figure 59: Europe Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2018-2026
Figure 60: Europe Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2018-2026
Figure 61: Europe Neuropathic Pain Management Market Attractiveness Analysis By Country, 2018-2026
Figure 62: Asia-Pacific Neuropathic Pain Management Market Value Share By Drug Class (2018 E)
Figure 63: Asia-Pacific Neuropathic Pain Management Market Value Share By Indication (2018 E)
Figure 64: Asia-Pacific Neuropathic Pain Management Market Value Share By Distribution Channel (2018 E)
Figure 65: Asia-Pacific Neuropathic Pain Management Market Value Share By Country (2018 E)
Figure 66: Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 67: Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 68: Japan Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 69: Japan Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 70: China Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 71: China Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 72: India Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 73: India Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 74: Australia and New Zealand Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 75: Australia and New Zealand Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 76: ASEAN Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 77: ASEAN Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 78: Rest of Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 79: Rest of Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 80: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2018-2026
Figure 81: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2018-2026
Figure 82: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2018-2026
Figure 83: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Country, 2018-2026
Figure 84: MEA Neuropathic Pain Management Market Value Share By Drug Class (2018 E)
Figure 85: MEA Neuropathic Pain Management Market Value Share By Indication (2018 E)
Figure 86: MEA Neuropathic Pain Management Market Value Share By Distribution Channel (2018 E)
Figure 87: MEA Neuropathic Pain Management Market Value Share By Country (2018 E)
Figure 88: MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 89: MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 90: South Africa Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 91: South Africa Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 92: GCC Countries Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 93: GCC Countries Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 94: Rest of MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2013-2017
Figure 95: Rest of MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 96: MEA Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2018-2026
Figure 97: MEA Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2018-2026
Figure 98: MEA Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2018-2026
Figure 99: MEA Neuropathic Pain Management Market Attractiveness Analysis By Country, 2018-2026
Figure 100: Global Neuropathic Pain Management Market Share Analysis (%), By Region, 2018 & 2026
Figure 101: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Region, 2018-2026
Figure 102: Global Neuropathic Pain Management Market Attractiveness Analysis By Region, 2018-2026
Figure 103: Global Neuropathic Pain Management Market Share Analysis (%), By Drug Class, 2018 & 2026
Figure 104: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Drug Class, 2018-2026
Figure 105: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Tricyclic Anti Depressants, 2013-2017
Figure 106: Global Tricyclic Neuropathic Pain Management Market Value Analysis (US$ Mn),  By Tricyclic Anti Depressants, 2018-2026
Figure 107: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Anticonvulsants, 2013-2017
Figure 108: Global Neuropathic Pain Management Market Value Analysis (US$ Mn),  By Anticonvulsants, 2018-2026
Figure 109: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By SNRI's, 2013-2017
Figure 110: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By SNRI's, 2018-2026
Figure 111: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Capsaicin Cream, 2013-2017
Figure 112: Global Capsaicin Cream Neuropathic Pain Management Market Value Analysis (US$ Mn), By Capsaicin Cream, 2018-2026
Figure 113: Global Neuropathic Pain Management Market Value Analysis (US$ Mn),  By Local Anesthesia 2013-2017
Figure 114: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Local Anesthesia , 2018-2026
Figure 115: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Opioids 2013-2017
Figure 116: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Opioids, 2018-2026
Figure 117: Global Neuropathic Pain Management Market Value Analysis (US$ Mn),  By Steroids , 2013-2017
Figure 118: Global Neuropathic Pain Management Market Value Analysis (US$ Mn),By Steroids, 2018-2026
Figure 119: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), by Others, 2013-2017
Figure 120: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Others, 2018-2026
Figure 121: Global Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2018-2026
Figure 122: Global Neuropathic Pain Management Market Share Analysis (%), By Indication , 2018 & 2026
Figure 123: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Indication , 2018-2026
Figure 124: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Diabetic Neuropathy, 2013-2017
Figure 125: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Diabetic Neuropathy, 2018-2026
Figure 126: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Trigeminal Neuralgia, 2013-2017
Figure 127: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Trigeminal Neuralgia, 2018-2026
Figure 128: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Post-Herpetic Neuralgia, 2013-2017
Figure 129: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Post-Herpetic Neuralgia, 2018-2026
Figure 130: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By CIPN, 2013-2017
Figure 131: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By CIPN, 2018-2026
Figure 132: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Post-Herpetic Neuralgia, 2013-2017
Figure 133: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Post-Herpetic Neuralgia, 2018-2026
Figure 134: Global Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2018-2026
Figure 135: Global Neuropathic Pain Management Market Share Analysis (%), By Distribution Channel, 2018 & 2026
Figure 136: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Distribution Channel, 2018-2026
Figure 137: Global Neuropathic Pain Management Market Value Analysis (US$ Mn),  By Retail Pharmacies, 2013-2017
Figure 138: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Retail Pharmacies, 2018-2026
Figure 139: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By  Hospital Pharmacies, 2013-2017
Figure 140: Global Neuropathic Pain Management Market Value Analysis (US$ Mn),  By Hospital Pharmacies, 2018-2026
Figure 141: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Online Pharmacies, 2013-2017
Figure 142: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), By Online Pharmacies, 2018-2026
Figure 143: Global Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2018-2026
Figure 144: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), 2012–2016
Figure 145: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), 2018-2026
Figure 146: Global Neuropathic Pain Management Market Absolute $ Opportunity, 2018 - 2026

Looking for customized information specific to your area of business?

Ask An Expert

Need information on something not covered here?

Request Advisory